Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02277639 · ClinicalTrials.gov registry record · Phase 2
Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases
A Phase 2 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT02277639 is a Phase 2 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 2 participants.
The verdict
NCT02277639, a Phase 2 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a Phase II trial to determine the ability of a reduced intensity conditioning regimen to allow successful engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two conditioning regimens depending upon patient diagnosis and age.
Interventions
- DEVICE CliniMACs device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-11 |
| Est. Completion | 2016-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02277639
The ClinicalTrials.gov registry entry for NCT02277639 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CliniMACs device is the first listed.
NCT02277639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02277639 about?
NCT02277639 is a clinical study titled "Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases". This is a Phase II trial to determine the ability of a reduced intensity conditioning regimen to allow successful engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two conditioning regimens depending upon patient diagnosis and age.
What is the current status of trial NCT02277639?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2011-11. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02277639?
The interventions under investigation include: CliniMACs device (DEVICE).
Who is sponsoring clinical trial NCT02277639?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.